Learning Objectives

  1. Discuss risks of malignancy in bariatric patients
  2. Contraindication to surgery due to Barrett’s debate
  3. Epidemiology of Barrett’s in bariatric surgery
  4. Endoscopic/pH studies pre/post operatively

8:45am Welcome
John Morton, MD MPH FACS; Jaime Ponce, MD FASMBS
8:50am Barrett’s esophagus: what is it? how frequent is in obese patients?
Teresa LaMasters, MD
9:05am Management of Barrett’s and risk of cancer
Marina Kurian, MD FASMBS
9:20am What is the incidence of “de novo” reflux and Barrett’s after sleeve?
Anthony Petrick, MD FASMBS
9:35am Are endoscopy and/or pH studies needed on every sleeve patient?
John Morton, MD MPH FACS
9:50am Panel: Q & A
10:10am Break
10:25am Is reflux a contraindication for sleeve?
Tammy Kindel, MD PhD FASMBS
10:55am Is Barrett’s a contraindication for sleeve?
Raul Rosenthal, MD
11:30am Post-op surveillance after Sleeve and management of reflux
Mona Misra, MD FASMBS
11:45am Panel: Q & A
12:15pm Adjourn